Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression

Cancer Letters

Volumn 145, Issue 1-2, 1999, Pages 17-27

  Chiu, Lawrence C M ^a   Wan, Jennifer M F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Bcl 2; Cell cycle; Eicosapentaenoic acid; Flow cytometry; Human leukemic cells

Indexed keywords

ICOSAPENTAENOIC ACID; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; DOWN REGULATION; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL;

APOPTOSIS; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; EICOSAPENTAENOIC ACID; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0032886232     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00224-4     Document Type: Article

References (57)

1. Agarwal N., Mehta K. Possible involvement of bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells. Biochem. Biophys. Res. Commun. 230:1997;251-253.
2. Anderson K.M., Seed T., Plate J.M.D., Jajeh A., Meng J., Harris J.E. Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induced limited differentiation and apoptosis. Leuk. Res. 19:1995;789-801.
3. Anel A., Naval J., Desportes P., González B., Uriel J., Piñeiro A. Increased cytotoxicity of polyunsaturated fatty acids on human tumoral B and T-cell lines compared with normal lymphocytes. Leukemia. 6:1992;680-688.
4. Arai S. Studies on functional foods in Japan - state of the art. Biosci. Biotechnol. Biochem. 60:1996;9-15.
5. Bégin M.E., Ells G., Das U.N., Horrobin D.F. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukotrienes Med. 77:1986;1053-1060.
6. Benito A., Lerga A., Silva M., Leon J., Fernandez L.J.L. Apoptosis of human myeloid leukemia cells induced by an inhibitor of protein phosphatases (okadaic acid) is prevented by Bcl-2 and bcl-x(L). Leukemia. 11:1997;940-944.
7. Blandino C., Scardigli R., Rizzo M.G., Crescenzi M., Soddu S., Sacchi A. Wild-type p53 modulates apoptosis of normal. IL-3 deprived, hematopoietic cells. Oncogene. 10:1995;731-737.
8. Boersma A.W.M., Nooter K., Oostrum R.G., Stoter G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin. Cytometry. 24:1996;123-130.
9. Burns C.P., Spector A.A. Effects of lipids on cancer therapy. Nutr. Rev. 48:1990;233-239.
10. Chen M., Quintans J., Fuks Z., Thompson C., Kufe D.W., Weichselnbaum R.R. Suppression of bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor α and ceramide. Cancer Res. 55:1995;991-994.
11. Cohen J.J. Programmed cell death in the immune system. Adv. Immunol. 50:1991;55-85.
12. Collins R.J., Harmon B.V., Gobe G.C., Kerr J.F.R. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol. 61:1992;451-453.
13. Darzynkiewicz Z. Apoptosis in antitumor strategies: modulation of cell cycle or differentiation. J. Cell. Biochem. 58:1995;151-159.
14. Darzynkiewicz Z., Juan G., Li X., Gorczyca W., Murakami T., Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry. 27:1997;1-20.
15. Das U.N. Agranulocytosis, aplastic anemia, and leukemia: relevance to arachidonic acid metabolism. Prostaglandins Leukot. Essent. Fatty Acids. 39:1990;217-220.
16. Engeland M.V., Ramaekers F.C.S., Schutte B., Reutelingsperger C.P.M. novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry. 24:1996;131-139.
17. Fernandes G., Chandrasekar B., Luan X., Troyer D.A. Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids. 31:1996;s91-s96.
18. Finstad H.S., Kolset S.O., Holme J.A., Wiger R., Farrants A.K.O., Blomhoff R., Drevon C.A. Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells. Blood. 84:1994;3799-3809.
19. Galli C., Butrum R. Dietary ω3 fatty acids and cancer: an overview. Simopoulos A.P., Kifer R.R., Martin R.E., Barlow S.M. Health Effects of ω3 Polyunsaturated Fatty Acids in Seafoods. 1991;447-461 Karger Press, Basel.
20. Glaspy J. Nutritional, hormonal, and environmental mechanisms in breast tumorigenesis. Heber A., Kritchevsky E. Dietary Fats, Lipids, Hormones and Tumorigenesis. 1993;27-39 Plenum Press, New York.
21. Griller I., Umiel T., Elstner E., Collins S.J., Koeffler H.P. Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RAR alpha-altered sublines of HL-60. Leukemia. 11:1997;393-400.
22. Hartwell L. Introduction to cell cycle control. Hutchison C., Glover D.M. Cell Cycle Control. 1995;1-15 Oxford University Press, New York.
23. Horrobin D. Fatty acids and cancer. Galli G., Simpopoulos A.P., Tremoli E. Effects of Fatty Acids and Lipids in Health and Disease. 1994;64-65 Karger Press, Basel.
24. Huang Y., Ibrado A.M., Reed J.C., Bullock G., Ray S., Tang C., Bhalla K. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Leukemia. 11:1997;253-257.
25. Jacobson M.D., Burnett J.F., King M.D., Miyashita T., Reed J.C., Raff M.C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature. 361:1993;365-369.
26. Kaizer L., Boyd N.F., Kriukov V., Tritchler D. Fish consumption and breast cancer risk: an ecological study. Nutr. Cancer. 12:1989;61-68.
27. Kaneko Y., Tsukamoto A. Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promoters. Cancer Lett. 91:1995;11-17.
28. Karmali R.A., Adams L., Trout J.R. Plant and marine n-3 fatty acids inhibit experimental metastasis of rat mammary adenocarcinoma cells. Prostaglandins Leukot. Essent. Fatty Acids. 48:1993;309-314.
29. Kerr J.F.R., Winterford C.M., Harmon B.V. Apoptosis: its significance in cancer and cancer therapy. Cancer. 73:1994;2013-2026.
30. Kerr J.F.R., Wyllie A.H., Currie A.R. basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
31. Koskelo E.K., Boswell K., Carl L., Lanoue S., Kelly C., Kyle D. High levels of dietary arachidonic acid triglyceride exhibit no subchronic toxicity in rats. Lipids. 32:1997;397-405.
32. Lai P.B.S., Ross J.A., Fearon K.C.H., Anderson J.D., Carter D.C. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br. J. Cancer. 74:1996;1375-1383.
33. Liu X.H., Rose D.P. Stimulation of type IV collagenase expression by linoleic acid in a metastatic human breast cancer cell line. Cancer Lett. 76:1994;71-77.
34. Liu X.H., Rose D.P. Suppression of type IV collagenase in MDA-MB-435 human breast cancer cells by eicosapentaenoic acid in vitro and in vivo. Cancer Lett. 92:1995;21-26.
35. Majno G., Joris I. Apoptosis, oncosis and necrosis: an overview of cell death. Am. J. Pathol. 146:1995;3-15.
36. Mariano M.T., Moretti L., Donelli A., Grantini M., Montagnani G., DiPrisco A.U., Torelli G., Torelli U., Narni F. bcl-2 Gene expression in hematopoietic cell differentiation. Blood. 80:1992;768-775.
37. Marzo I., Martínez-Lorenzo M.J., Anel A., Desportes P., Alava M.A., Naval J., Piñeiro A. Biosynthesis of unsaturated fatty acids in the main cell lineages of human leukemia and lymphoma. Biochim. Biophys. Acta. 1257:1995;140-148.
38. Mayer A.M.S., Brenic S., Glaser K.B. Pharmacological targeting of signaling pathways in protein kinase C-stimulated superoxide generation in neutrophil-like HL-60 cells: effect of phorbol ester, arachidonic acid and inhibitors of kinase(s), phosphate(s) and phospholipase A2. J. Pharmacol. Exp. Ther. 279:1996;633-644.
39. McConkey D.J., Chandr J., Wright S., Plunkett W., McDonnell T.J., Reed J.C., Keating M. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of bcl-2 and bax(. J. Immunol. 156:1996;2624-2630.
40. Mollindeo F., Fernandez L.J.L., Gajate C., Martin M.B., Benito A., Martinez D.R., Modolell M. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (edelfosine): molecular structure requirements, cellular uptake, and protection by bcl-2 and bcl-x(L). Cancer Res. 57:1997;1320-1328.
41. Murakami A., Ohigashi H., Koshimizu K. Anti-tumor promotion with food phytochemicals: a strategy for cancer chemoprevention. Biosci. Biotechnol. Biochem. 60:1996;1-8.
42. Noguchi M., Minami M., Yagasaki R., Kinoshita K., Earashi M., Kitagawa H., Taniya T., Miyazaki I. Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA. Br. J. Cancer. 75:1997;348-353.
43. Ohizumi H., Masuda Y., Yoda M., Hashimoto S., Aiuchi T., Nakajo S., Sakai I., Ohsawa S., Nakaya K. Induction of apoptosis in various tumor cell lines by geranylgeraniol. Anticancer Res. 17:1997;1051-1057.
44. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax that accelerates programmed cell death. Cell. 74:1993;609-619.
45. Phinney S.D. Metabolism of exogenous and endogenous arachidonic acid in cancer. Heber A., Kritchevsky E. Dietary Fats, Lipids, Hormones, and Tumorigenesis. 1996;87-94 Plenum Press, New York.
46. Ray C.A., Black R.A., Kronheim S.R., Greenstreet T.A., Sleath P.R., Salvesen G.S., Pickup D.J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell. 69:1992;597-604.
47. Salomons G.S., Brady H.J.M., Verwijs J.M., van-den-Berg J.D., Hart A.A.M., van-den-Berg H., Behrendt H., Hahlen K., Smets L.A. The baxα:bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukemia. Int. J. Cancer. 71:1997;959-965.
48. Sellmayer A., Danesch U., Weber P.C. Effects of different polyunsaturated fatty acids on growth related early gene expression and cell growth. Lipids. 31:1996;537-540.
49. Spector A.A., Burns C.P. Biological and therapeutic potential of membrane lipid modification in tumors. Cancer Res. 47:1987;4529-4537.
50. Steck K., McDonnell T., Sneige N., El-Naggar A. Flow cytometric analysis of apoptosis and bcl-2 in primary breast carcinomas: clinical and biological implications. Cytometry. 24:1996;116-122.
51. Strasser A., Harris A.W., Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:1991;889-899.
52. Sulston J.E., Schierenberg E., White J.G., Thomson J.N. The embryonic cell lineage of the nematode Caenorhabditis elegans. Develop. Biol. 100:1983;64-119.
53. Tsujimoto Y. Bcl-2: antidote for cell death. Kuchino Y., Müller W.E.G. Apoptosis. 1996;72-86 Springer-Verlag, New York.
54. Tsujimoto Y., Cossman J., Croce C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 228:1985;1440-1443.
55. Tsukada T., Nakashma K., Shirakawa S. Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines. Biochem. Biophys. Res. Commun. 140:1986;832-836.
56. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
57. Wyllie A.H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev. 11:1992;95-103.